Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin
- 862 Downloads
Cellular metabolic alterations are now well described as implicated in cancer and some strategies are currently developed to target these different pathways. In previous papers, we demonstrated that a combination of molecules (namely alpha-lipoic acid and hydroxycitrate, i.e. Metabloc™) targeting the cancer metabolism markedly decreased tumor cell growth in mice. In this work, we demonstrate that the addition of capsaicin further delays tumor growth in mice in a dose dependant manner. This is true for the three animal model tested: lung (LLC) cancer, bladder cancer (MBT-2) and melanoma B16F10. There was no apparent side effect of this ternary combination. The addition of a fourth drug (octreotide) is even more effective resulting in tumor regression in mice bearing LLC cancer. These four compounds are all known to target the cellular metabolism not its DNA. The efficacy, the apparent lack of toxicity, the long clinical track records of these medications in human medicine, all points toward the need for a clinical trial. The dramatic efficacy of treatment suggests that cancer may simply be a disease of dysregulated cellular metabolism.
KeywordsCancer Metabolism Metabloc Capsaicin Warburg
We acknowledge the help of Edward Sanders. The studies were performed by Nosco Pharmaceuticals (France). This work was funded by Biorébus.
Conflict of interest
METABLOC is a trade mark of Biorébus.
AG is an employee of Biorébus. The other authors declare that they have no competing interests.
- 2.Abolhassani M, Guais A, Sanders E, Campion F, Fichtner I, Bonte Jacques, Baronzio G, Fiorentini G, Israel M, Schwartz L (2011) Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice. Invest New Drugs. doi: 10.1007/s10637-011-9692-7, In press
- 13.Pardee TS, Levitan D, Hurd D (2011) Altered mitochondrial metabolism as a target in acute myeloid leukemia. ASCO Congress PosterGoogle Scholar
- 14.Lee K, Khaira D, Rodriguez R, Maturo C, O’Donnell K, Shorr R (2011) Case study: long-term stable disease of stage IV pancreatic neuroendocrine tumors and without significant adverse effect by CPI-613, an investigational novel anti-cancer agent. Case Study Case Report 1:137–145Google Scholar
- 15.Guais A, Baronzio G, Sanders E, Campion F, Mainini C, Fiorentini G, Montagnani F, Behzadi M, Schwartz L, Abolhassani M (2012) Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumour development: experimental results and case report. Invest New Drugs 30:200–211. doi: 10.1007/s10637-010-9552-x PubMedCrossRefGoogle Scholar
- 18.Ito K, Nakazato T, Yamato K, Miyakawa Y, Yamada T, Hozumi N, Segawa K, Ikeda Y, Kizaki M (2004) Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res 64:1071–1078. doi: 10.1158/0008-5472.CAN-03-1670 PubMedCrossRefGoogle Scholar
- 19.Thoennissen NH, O’Kelly J, Lu D, Iwanski GB, La DT, Abbassi S, Leiter A, Karlan B, Mehta R, Koeffler HP (2010) Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and –negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene 29:285–296. doi: 10.1038/onc.2009.335 PubMedCrossRefGoogle Scholar
- 20.Choi CH, Jung YK, Oh SH (2010) Autophagy induction by capsaicin in malignant human breast cells is modulated by p38 and extracellular signal-related mitogen-activated protein kinases and retards cell death by suppressing endoplasmic reticulum stress-mediated apoptosis. Mol Pharmacol 78:114–125. doi: 10.1124/mol.110.063495 PubMedCrossRefGoogle Scholar
- 28.Mori A, Lehmann S, O’Kelly J, Kumagai T, Desmond JC, Pervan M, McBride WH, Kizaki M, Koeffler HP (2006) Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res 66:3222–3229. doi: 10.1158/0008-5472.CAN-05-0087 PubMedCrossRefGoogle Scholar
- 31.Wolvertang EJ, Larm JA, Moutsoulas P, Lawen A (1996) Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ 7:1315–1325Google Scholar
- 38.Chueh PJ, Wu LY, Morré DM, Morré DJ (2004) tNOX is both necessary and sufficient as a cellular target for the canticancer activity of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate. Biofactors 20:249–263Google Scholar
- 41.Sanchez AM, Malagarie-Cazenave S, Olea N, Vara D, Chileoches A, Diaz-Laviada I (2007) Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation. Apoptosis 12:2013–2024. doi: 10.1007/s10495-007-0119-z PubMedCrossRefGoogle Scholar